Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient

  1. J. A. Douglass*,
  2. K. Carroll,
  3. A. Voskamp,
  4. P. Bourke,
  5. A. Wei,
  6. R. E O’Hehir

Article first published online: 4 NOV 2009

DOI: 10.1111/j.1398-9995.2009.02259.x

Issue

Allergy

Allergy

Volume 65, Issue 7, pages 926–927, July 2010

Additional Information

How to Cite

Douglass, J. A., Carroll, K., Voskamp, A., Bourke, P., Wei, A. and O’Hehir, R. E. (2010), Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient. Allergy, 65: 926–927. doi: 10.1111/j.1398-9995.2009.02259.x

Author Information

* Department of Allergy, Immunology and Respiratory Medicine The Alfred Hospital and Monash University 5th Floor, Commercial Road Melbourne 3004 Victoria Australia Tel.:+61 3 9076 2934 Fax:+61 3 9076 2245 E-mail: J.Douglass@alfred.org.au

Publication History

  1. Issue published online: 1 JUN 2010
  2. Article first published online: 4 NOV 2009
  3. Accepted for publication 6 October 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (276K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (276K)